InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,682.40
(
0.00%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.85
(
0.56%
)
Bitcoin
62,618.08
(
1.90%
)
Post# of 6315
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

cjarmstrong

Send PM Follow Ignore
Followers 0
Posts 157
Boards Moderated 0
Alias Born 04/28/2017

cjarmstrong

Re: Vinpat post# 2137

Friday, 05/12/2017 12:39:55 AM

Friday, May 12, 2017 12:39:55 AM

Post# of 6315
Most likely. Insys filed an NDA for their dronabinol sublingual spray in Aug 2014 and expect to release it this year.

Not sure why Nemus is going with rectal delivery over sublingual, transdermal, or buccal (though it has been mentioned) - all of which avoid first pass effect. Suppositories have low patient acceptance.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SKYE News
More SKYE News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!